Sciaticon AB
Records under this name other than patents Sciaticon AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Sciaticon AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,649,589 | Use of certain drugs for treating nerve root injury Lapsed on the fee record Ended Nov 18, 2015 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2015 | From the USPTO record |
| US 8,057,792 | Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus Lapsed on the fee record Ended Nov 15, 2015 · From the USPTO record | Lapsed on the fee record | Ended Nov 15, 2015 | From the USPTO record |
| US 6,635,250 | Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus Lapsed on the fee record Ended Oct 21, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 21, 2015 | From the USPTO record |
| US 7,906,481 | Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus Lapsed on the fee record Ended Mar 15, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 15, 2015 | From the USPTO record |
| US 7,811,990 | Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus Lapsed on the fee record Ended Oct 12, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 12, 2014 | From the USPTO record |
| US 7,115,557 | Use of certain drugs for treating nerve root injury Lapsed on the fee record Ended Oct 3, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 3, 2014 | From the USPTO record |
| US 7,723,357 | Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus Lapsed on the fee record Ended May 25, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 25, 2014 | From the USPTO record |
| US 7,708,995 | Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus Lapsed on the fee record Ended May 4, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2014 | From the USPTO record |